10 days ago
COGT
AnalystsMichael SchmidtMichael Schmidt's Stock Forecasts
AnalystsMichael Schmidt
Analyst Ranking
Top 2%
#75 out of 5497 analysts
Average Return
+47.9%
Win Rate
65%92 out of 141
Risk vs Reward
Poor
Good
Michael Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nanobiotix SaNBTX | +850.69% | $3.27 | $31.04 | 2025-04-04 - 2026-04-02 | Strong Buy |
Urogen Pharma LtdURGN | +613.13% | $4.19 | $29.88 | 2025-05-23 - 2026-05-21 | Strong Buy |
Tango Therapeutics IncTNGX | +342.92% | $6.50 | $28.79 | 2025-08-06 - 2026-08-05 | Strong Buy |
Revolution Medicines IncRVMD | +341.99% | $38.41 | $169.77 | 2025-06-25 - 2026-06-24 | Strong Buy |
Relay Therapeutics IncRLAY | +337.97% | $2.95 | $12.92 | 2025-05-07 - 2026-05-06 | Strong Buy |
Michael Schmidt Analyst Color
Get additional color on Michael Schmidt's coverage of popular stocks
10 days ago
TNGX
15 days ago
GMAB
16 days ago
RVMD
a month ago
RVMD
2 months ago
GLUE
3 months ago
ONC
4 months ago
RVMD
5 months ago
NBTX
5 months ago
CTMX
5 months ago
ERAS
6 months ago
TNGX
6 months ago
ONC
7 months ago
RVMD
8 months ago
IMNM
a year ago
CMPX
a year ago
ADCT
a year ago
VSTM
2 years ago
RVMD
2 years ago
EXEL
3 years ago
EXEL
3 years ago
SNDX
4 years ago
ONC
5 years ago
ACET
Michael Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adc Therapeutics SaADCT | 7 | Strong Buy | $5.00 | +401.50% | Maintains | 5 days ago |
Cogent Biosciences IncCOGT | 2 | Strong Buy | $52.00 | +41.57% | Maintains | 10 days ago |
Tango Therapeutics IncTNGX | 4 | Strong Buy | $35.00 | +46.57% | Maintains | 10 days ago |
Cytomx Therapeutics IncCTMX | 4 | Strong Buy | $14.00 | +326.83% | Maintains | 12 days ago |
Monte Rosa Therapeutics IncGLUE | 5 | Strong Buy | $28.00 | +95.80% | Maintains | 15 days ago |
Genmab AGMAB | 4 | Strong Buy | $42.00 | +25.56% | Maintains | 15 days ago |
Verastem IncVSTM | 4 | Strong Buy | $12.00 | +74.17% | Maintains | 15 days ago |
Revolution Medicines IncRVMD | 9 | Strong Buy | $240.00 | +14.58% | Maintains | 16 days ago |
Parabilis Medicines IncPBLS | 1 | Strong Buy | $40.00 | +1.63% | Initiates Coverage On | 2 months ago |
Engene Therapeutics IncENGN | 1 | Hold | N/A | N/A | Downgrades | 3 months ago |
Beone Medicines LtdONC | 10 | Strong Buy | $420.00 | +12.16% | Maintains | 3 months ago |
Zentalis Pharmaceuticals IncZNTL | 5 | Strong Buy | $10.00 | +161.44% | Maintains | 4 months ago |
Nanobiotix SaNBTX | 4 | Strong Buy | $36.00 | -17.34% | Maintains | 5 months ago |
Compass Therapeutics IncCMPX | 6 | Strong Buy | $12.00 | +400.00% | Reiterates | 5 months ago |
Erasca IncERAS | 2 | Strong Buy | $20.00 | +13.44% | Maintains | 5 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $12.00 | +197.03% | Initiates Coverage On | 5 months ago |
Immunome IncIMNM | 4 | Strong Buy | $35.00 | +22.72% | Maintains | 8 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $12.00 | +69.73% | Initiates Coverage On | 9 months ago |
Incyte CorpINCY | 7 | Strong Buy | $125.00 | -2.20% | Upgrades | 10 months ago |
Mersana Therapeutics IncMRSN | 4 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Oric Pharmaceuticals IncORIC | 5 | Strong Buy | $18.00 | N/A | Reiterates | a year ago |
Arvinas IncARVN | 6 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $45.00 | N/A | Reiterates | a year ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $52.00 | N/A | Reiterates | a year ago |
Springworks Therapeutics IncSWTX | 3 | Hold | $47.00 | N/A | Reiterates | a year ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $32.00 | N/A | Reiterates | a year ago |
Merus NvMRUS | 5 | Strong Buy | $109.00 | N/A | Reiterates | a year ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Strong Buy | $1.75 | N/A | Maintains | a year ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Reiterates | a year ago |
Exelixis IncEXEL | 7 | Strong Buy | $42.00 | N/A | Reiterates | 2 years ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Blueprint Medicines CorpBPMC | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $20.00 | N/A | Reiterates | 2 years ago |
Immunocore Holdings PLCIMCR | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Adicet Bio IncACET | 4 | Strong Buy | $112.00 | N/A | Upgrades | 2 years ago |
Bolt Biotherapeutics IncBOLT | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Immuneering CorpIMRX | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Immunogen IncIMGN | 1 | Hold | $31.00 | N/A | Downgrades | 3 years ago |
Xencor IncXNCR | 2 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Strong Buy | $170.00 | N/A | Reiterates | 3 years ago |
Neurogene IncNGNE | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Rubius Therapeutics IncRUBY | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Cellectis SaCLLS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $39.00 | N/A | Maintains | 6 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Forty Seven IncFTSV | 1 | Strong Buy | $48.00 | N/A | Maintains | 7 years ago |
Bluebird Bio IncBLUE | 4 | Hold | N/A | N/A | Downgrades | 7 years ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $80.00 | N/A | Upgrades | 8 years ago |
Array Technologies IncARRY | 3 | Buy | N/A | N/A | Initiates Coverage On | 8 years ago |
Clovis Oncology IncCLVSQ | 2 | Hold | $30.00 | N/A | Initiates Coverage On | 8 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $24.00 | N/A | Reinstates | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | $87.00 | N/A | Downgrades | 9 years ago |
Arbutus Biopharma CorpABUS | 1 | Hold | $5.50 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.